Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Threshold Pharmaceuticals Inc (NASDAQ:THLD)

1.18
Delayed Data
As of 3:59pm ET
 +0.01 / +0.85%
Today’s Change
0.21
Today|||52-Week Range
4.44
+145.88%
Year-to-Date
No recent news for Threshold Pharmaceuticals Inc.

Today’s Trading

Previous close1.17
Today’s open1.18
Day’s range1.15 - 1.22
Volume1,221,236
Average volume (3 months)2,740,927
Market cap$83.7M
Dividend yield--
Data as of 3:59pm ET, 09/26/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-169.44%
Earnings growth (next 5 years)--
Revenue growth (last year)+422.45%
P/E ratio1.9
Price/Sales0.46
Price/Book2.05

Competitors

 Today’s
change
Today’s
% change
CEMIChembio Diagnostics ...+0.09+1.27%
ATNMActinium Pharmaceuti...+0.21+11.73%
AEGRAegerion Pharmaceuti...-0.10-3.64%
SPHSSophiris Bio Inc+0.26+8.78%
Data as of 4:02pm ET, 09/26/2016

Financials

Next reporting dateOctober 31, 2016
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$76.9M
Annual profit (last year)$43.8M
Net profit margin56.97%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Harold E. Selick
Chief Operating Officer
Stewart M. Kroll
Corporate headquarters
South San Francisco, California

Forecasts

Search for Jobs